What Iterative Health Announced About Buying the NextStage Cardiology Sites
Iterative Health said on 14 May 2026 that it had acquired three cardiology research sites from NextStage Clinical Research, located in Beaumont, Port Arthur and Waco, Texas. Jonathan Ng, founder and chief executive of Iterative Health, is quoted calling the established sites a key addition as the company builds out its cardiology focus within its global network. Donald S. Cross, a cardiologist and principal investigator at Waco Cardiology Associates, is quoted calling the move a natural next step for the site staff and the patients they serve. The announcement states no purchase price and no other financial terms. A later Waco Tribune-Herald report carried on the same newsroom, dated 8 June 2026, adds that the Waco research operation had 200 to 250 trial participants enrolled.
Why the Iterative Health Cardiology Site Purchase Matters to Trial Sponsors
This is a company buying the thing it used to sell software to. Iterative Health has been measuring trials with AI; owning the sites means it now controls enrolment, the scarcest resource in clinical research, and can promise a sponsor patients rather than tools. It also moves the company into cardiology, a long way from the gut disease work it is known for. The risk sits in the same place as the value. A research site is mostly its principal investigator and the patients who trust that person, and neither is a transferable asset. The quote from the Waco investigator reads as a signal that the staff are staying, which is exactly what a buyer needs, but it is a statement of intent made on the day of the deal. With no price disclosed, there is also no way to judge what the company paid for 200 to 250 enrolled patients, which is the number that makes a site worth owning.
Where the Iterative Health Update Comes From
Iterative Health is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
Iterative Health original source.
How We Would Research the Iterative Health Cardiology Site Purchase
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would start by asking Iterative Health how many of the three sites are still enrolling a year on, because enrolment is what was bought and site counts hide it.
- Then we would look for whether the principal investigators named at the time are still listed, since a research site largely is its investigators.
- We would ask a sponsor running a study at one of these sites whether anything changed after the sale, because that is the only party with no reason to flatter the deal.